Summary & Overview
HCPCS S9810: Home Pharmacy Infusion and Specialty Drug Management
HCPCS Level II code S9810 denotes professional pharmacy services delivered in the home to support infusion therapy, specialty drug administration, and disease state management, billed on an hourly basis. As a code describing hands-on pharmacy clinical support in the home setting, S9810 captures services that enable complex medication administration outside traditional clinical sites, supporting patient-centered care and reduced facility utilization.
Key payers considered in this national overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code's clinical intent and service setting, where it fits in home infusion and specialty pharmacy workflows, and which payers commonly address coverage for home-based pharmacy services. The publication also outlines expected benchmarks and policy considerations relevant to billing and claims processing, and highlights areas where payer policy variations and documentation requirements commonly influence utilization and reimbursement.
This summary is intended to inform billing staff, pharmacy administrators, and policy analysts about the scope and use of S9810 at a national level, helping stakeholders understand coding context, payer engagement, and operational implications for delivering home infusion and specialty drug services.
Billing Code Overview
HCPCS Level II code S9810 describes home therapy professional pharmacy services for the provision of infusion, specialty drug administration, and disease state management, billed per hour. The code is intended for pharmacy professionals delivering clinical and technical services in the home setting to support infusion therapy or specialty medication administration and associated disease-state management activities. Typical site of service is the patient's home and the service type is home-based pharmacy clinical services and infusion support.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient with advanced rheumatoid arthritis receiving home infusion of a biologic disease-modifying antirheumatic drug (DMARD) requires ongoing professional pharmacy management for drug preparation, infusion oversight, and disease-state monitoring. A home infusion pharmacist visits the patient’s residence or provides telehealth-based professional services coordinated with a visiting nurse. Services include review of the patient’s medication profile, aseptic preparation of the specialty infusion or injection, dose verification, infusion set-up, patient education on adverse effects and self-monitoring, documentation of infusion tolerance, and coordination with the prescribing physician for any dosage adjustments or adverse events. Billing uses S9810 per hour for the professional pharmacy services component; it is not used with per diem home infusion codes. Typical workflow steps: pre-visit chart review and prior authorization confirmation; medication compounding and bedside verification; patient assessment and vital signs review; infusion administration supervision and troubleshooting; post-infusion assessment and documentation; communication of outcomes to the ordering clinician and payer as needed.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when the professional pharmacy service requires substantially greater resources or complexity than usual, documented with supporting rationale and time. |